A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| PF-04447943 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. |  |
| PF-04449613 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04449613 | PF-04449613 is a selective PDE9A inhibitor with an IC50 of 22 nM[1]. PF-04449613 improved motor learning ability in a mouse model[2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1236858-52-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12788. |  |
| PF-04449913 maleate salt | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04455242 hydrochloride | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04457845 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04471141 hydrochloride | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04479745 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04531083 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04620110 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04620110 | PF-04620110 is a potent, selective and orally bioavailable diglyceride acyltransferase-1 (DGAT-1) inhibitor with an IC 50 of 19 nM [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1109276-89-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-13009. | |
| PF-04634817 succinate | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04671536 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04691502 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04691502 | PF-04691502 is a potent and selective inhibitor of PI3K and mTOR. PF-04691502 binds to human PI3Kα, β, δ, γ and mTOR with K i s of 1.8, 2.1, 1.6, 1.9 and 16 nM, respectively. Uses: Scientific research. Group: Signaling pathways. CAS No. 1013101-36-4. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-15177. | |
| PF 04691502 (2-Amino-8-[trans-4-(2-hydroxyethoxy )cyclohexyl]-6-(6-methoxy-3-pyridinyl)-4-methyl-py rido[2,3-d]pyrimidin-7(8H)-one) | Potent and selective dual ATP-competitive PI 3-K/mTOR inhibitor (Ki values are 1.6, 1.8, 1.9, 2.1 and 16nm for human PI 3-K delta, alpha, gamma, beta, and mTOR, respectively). Displays no significant inhibitory activity at more than 80 protein kinases (concentration ≥ 10um) including hVps34, PI 3-K downstream kinases, and MAPK family members. Orally available. Induces robust cell cycle arrest at the G1 phase in U87MG cancer cells and antitumor activity in SKOV3 ovarian cancer xenograft models. Group: Biochemicals. Grades: Highly Purified. CAS No. 1013101-36-4. Pack Sizes: 5mg, 25mg. US Biological Life Sciences. |  Worldwide |
| PF-04701475 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04725379 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04753299 | ?98%. Group: Fluorescence/luminescence spectroscopy. | |
| PF-04802367 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04802367 | PF-04802367 (PF-367) is a highly selective GSK-3 inhibitor with an IC50 of 2.1 nM based on a recombinant human GSK-3? enzyme assay and 1.1 nM based on ADP-Glo assay. PF-04802367 shows desirable central nervous system (CNS) properties and potency. PF-04802367 is equally effective at inhibition of the two known GSK-3 isoforms (GSK-3? and GSK-3?) with IC50 values of 10.0 and 9.0 nM in mobility shift assays, respectively[1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PF-367. CAS No. 1962178-27-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-122026. | |
| PF-04827736 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04856264 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04859989 | PF-04859989 Inhibitor. Uses: Scientific use. Product Category: T28368. CAS No. 177943-33-8. |  |
| PF-04859989 hydrochloride | PF-04859989 hydrochloride is a brain-penetrant, irreversible kynurenine aminotransferase (KAT) II inhibitor with IC 50 s of 23 and 263 nM for hKAT II and rKAT II. PF-04859989 hydrochloride is selective for KAT II over human KAT I, KAT III, and KAT IV (IC50s of 22, 11, and >50 μM, respectively) [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 177943-33-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-116451. | |
| PF-04859989 hydrochloride | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04880594 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04885614 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04957325 | PF-04957325 is a highly potent and selective PDE8 inhibitor, with IC50s of 0.7 nM and 0.3 nM for PDE8A and PDE8B, respectively. Uses: Scientific research. Group: Signaling pathways. CAS No. 1305115-80-3. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-15426. | |
| PF-04979064 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-04995274 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-05020182 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-05085727 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF 05089771 | PF 05089771 is a potent, orally active and selective arylsulfonamide Na v 1.7 inhibitor, with IC 50 values of 11 nM, 12 nM, 13 nM, 171 nM and 8 nM for hNa v 1.7, cynNa v 1.7, dogNa v 1.7, ratNa v 1.7, and musNa v 1.7, respectively. PF 05089771 is under the study for pain and diabetic neuropathy [1] [2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1235403-62-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12883. | |
| PF-05089771 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-05105679 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-05175157 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-05175157 | PF-05175157 is broad spectrum acetyl-CoA carboxylase (ACC) inhibitor with IC50s of 27.0, 33.0, 23.5 and 50.4 nM for ACC1 (human), ACC2 (human), ACC1 (rat), ACC2 (rat), respectively. Uses: Scientific research. Group: Signaling pathways. CAS No. 1301214-47-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12942. | |
| PF-05180999 | PF-05180999 (PF-999) is a phosphodiesterase 2A (PDE2A) inhibitor, with an IC 50 of 1.6 nM. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PF-999. CAS No. 1394033-54-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-111371. | |
| PF-05180999 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-05212384 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF 05212384 (PKI-587) (N-[4-[[4-(Dimethylamino)-1-piperidi nyl]carbonyl]phenyl]-N'-[4-(4,6-di-4-morpholinyl-1, 3,5-triazin-2-yl)phenyl]urea) | Potent and selective dual inhibitor of PI 3-kinase/mTOR (IC50 values are 0.4, 1.6 and 5.4nm for PI 3-Kalpha, mTOR and PI 3-Kgamma respectively). Exhibits selectivity over 234 other protein kinases (IC50 >10um). Potently inhibits tumor cell growth in 37 different tumor cell lines (IC50 < 100nm). Also exhibits antitumor activity in MDA-361, HCT-116, H1975 and U87MG xenograft models. Group: Biochemicals. Grades: Highly Purified. CAS No. 1197160-78-3. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| PF-05221304 | PF-05221304 Inhibitor. Uses: Scientific use. Product Category: T9209. CAS No. 1370448-25-1. | |
| PF-05236216 hydrochloride | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-05274857 Hydrochloride | PF-05274857 Hydrochloride. Group: Biochemicals. Alternative Names: 1-(4-(5'-Chloro-3,5-dimethyl-[2,4'-bipyridin]-2'-yl)piperazin-1-yl)-3-(methylsulfonyl)propan-1-one Monohydrochloride. Grades: Highly Purified. Pack Sizes: 2.5mg. Molecular Formula: C20H26Cl2N4O3S, Molecular Weight: 473.42. US Biological Life Sciences. | Worldwide |
| PF-05883083-00 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06250112 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06260933 | PF-06260933 is an orally active and highly selective inhibitor of MAP4K4 with IC50s of 3.7 and 160 nM for kinase and cell, respectively. Uses: Scientific research. Group: Signaling pathways. CAS No. 1811510-56-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-19562. | |
| PF-06260933 dihydrochloride | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06263276 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06273340 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06281355 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06282999 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06282999 | PF-06282999 is a potent and selective myeloperoxidase inhibitor which is potential useful for the treatment of cardiovascular diseases. Uses: Scientific research. Group: Signaling pathways. CAS No. 1435467-37-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-19321. | |
| PF-06284674 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06297470 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06305591 dihydrate | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06372865 | PF-06372865 is an orally active, α2/α3/α5 subtype-selective GABA A positive allosteric modulator (PAM). PF-06372865 is a high affinity ligand at GABA A receptors containing α1/α2/α3/α5 subunits ( K i s of 2.9 nM, 21 nM, 134 nM for α2, α1 PAM, α2 PAM, respectively), with low affinity for α4/α6 subunits. PF-06372865 can across the blood-brain barrier (BBB). PF-06372865 has anxiolytic activity and has the potential for epilepsy [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1614245-70-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-120874. | |
| PF-06380101 | PF-06380101 is a novel cytotoxic Dolastatin 10 analogue; with excellent potencies in tumor cell proliferation assays and differential ADME properties when compared to other synthetic auristatin analogues that are used in the preparation of ADCs. Uses: Adcs cytotoxin. Synonyms: PF-06380101; PF 06380101; PF06380101; Auristatin 0101; AUR-0101; AUR 0101; AUR0101. Grade: >98%. CAS No. 1436391-86-4. Molecular formula: C39H62N6O6S. Mole weight: 743.01. |  |
| PF-06409577 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06409577 | PF-06409577 is a potent and selective allosteric activator of AMPK ?1?1?1 isoform with an EC50 of 7 nM. Uses: Scientific research. Group: Signaling pathways. CAS No. 1467057-23-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-103683. | |
| PF-06422913 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06424439 | PF-06424439 is an oral, potent and selective imidazopyridine diacylglycerol acyltransferase 2 (DGAT2) inhibitor with an IC50 of 14 nM[1]. PF-06424439 is slowly reversible, time-dependent inhibitor, which inhibits DGAT2 in a noncompetitive mode with respect to the acyl-CoA substrate[2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1469284-78-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg. Product ID: HY-108341. | |
| PF-06424439 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06424439 methanesulfonate | PF-06424439 methanesulfonate is an oral, potent and selective imidazopyridine diacylglycerol acyltransferase 2 (DGAT2) inhibitor with an IC50 of 14 nM[1]. PF-06424439 methanesulfonate is slowly reversible, time-dependent inhibitor, which inhibits DGAT2 in a noncompetitive mode with respect to the acyl-CoA substrate[2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1469284-79-4. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-108341A. | |
| PF-06439015 methanesulfonate salt | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06442609 | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06446846 hydrochloride | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PF-06446846 hydrochloride | PF-06446846 hydrochloride is an orally active and highly selective inhibitor of translation of Proprotein convertase subtilisin/kexin type 9 (PCSK9). PF-06446846 hydrochloride inhibits PCSK9 by inducing the ribosome to stall around codon 34[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1632250-50-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-120088A. | |
| PF-06447475 | PF-06447475 is a highly potent, selective and brain penetrant LRRK2 inhibitor with an IC50 of 3 nM. Uses: Scientific research. Group: Signaling pathways. CAS No. 1527473-33-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg. Product ID: HY-12477. | |
Our database is helping our users find suppliers everyday.
